Dr Patricio Duarte speaks to ecancer at the ASH virtual 2020 congress about the management of multiple myeloma patients.
He initially outlines frailty evaluation in MM patients, and the comparison of data from real world studies to his patients in clinic.
Dr Duarte also discusses medical conduct with MM patients in biochemical relapse, particularly with note to the COVID-19 pandemic.
He finalises by touching on a couple of exciting papers from ASH 2020. He also speaks about his experiences in Argentina specifically, but emphasises that Latin America is not homogenous.
This programme has been supported by an unrestricted educational grant from Takeda.